Starpharma Holdings Limited announced that Dr. Jeff Davies has commenced as an independent non-executive director, effective 1 April 2022. Dr. Davies is a former CSL executive, with over 35 years of biopharmaceutical experience, holding senior executive roles at CSL, including Executive Vice President and General Manager at CSL for the Asia-Pacific region, and Global Head of Plasma Product Research and Development at CSL-Behring, Switzerland.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 AUD | -4.35% | -4.35% | -35.29% |
Apr. 08 | Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16% | MT |
Mar. 18 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.29% | 31.46M | |
+40.73% | 739B | |
+31.79% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.68% | 240B | |
+9.51% | 210B | |
-4.91% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- SPL Stock
- News Starpharma Holdings Limited
- Starpharma Holdings Limited Appoints Jeff Davies as Director